Driggs SD, Cruz AT, Laurencio GI

Language: Spanish
References: 7
Page:
PDF size: 164.70 Kb.

Text Extraction

No abstract.

REFERENCES

1. Mulet Pérez AM, Gámez Escalona MM, Tamayo Ochoa M, Escobar Bernal A, Pozo Allen H, Verdecia Carralero AM. Gastritis crónica antral por Helicobacter pylori y enfermedad por reflujo gastroesofágico. Correo Cient Méd Holguín. 2012 [citado 5 feb 2013]; 16 (4). Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/viewFile/522/243

2. Ramírez Ramos A, Sánchez R. Helicobacter pylori y cáncer gástrico. Rev Gastroenterol Perú. 2008; 28 (3): 258-66.

3. Correa P, Piazuelo MB. Natural history of helicobacter pylori infection. Dig Liver Dis. 2008; 40(7): 490–6.

4. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006; 19(3):449–90.

5. 5.Yoshida T, Kato J, Maekita T, Yamashita S, Enomoto S, Ando T, et al. Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis. Gastric Cancer. 2013 Jan 6.

6. Noto JM, Khizanishvili T, Chaturvedi R, Piazuelo MB, Romero-Gallo J, Delgado AG, et al. Helicobacter Pylori promotes the expression of Krüppel-Like Factor 5, a mediator of carcinogenesis, in vitro and in vivo. PLoS ONE. 2013 [citado 6 feb 2013]; 8(1). Disponible en: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054344

7. Wu XC, Andrews P, Chen VW, Groves FD. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences. Cancer Epidemiol. 2009; 33(5):337–46.